Digirad Corporation provides diagnostic solutions in the United States. The company operates in two segments, Diagnostic Services and Diagnostic Imaging. The company was founded in 1985 and is based in Suwanee, Georgia.
DRAD Price Forecast Based on DCF Valuation
DCF Fair Value Target:
The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Digirad Corp. To summarize, we found that Digirad Corp ranked in the 3th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 99%. In terms of the factors that were most noteworthy in this DCF analysis for DRAD, they are:
Interest coverage, a measure of earnings relative to interest payments, is -2.88 -- which is good for besting only 14.92% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
The company's compound free cash flow growth rate over the past 5.44 years comes in at -0.38%; that's greater than merely 3.2% of US stocks we're applying DCF forecasting to.
Terminal Growth Rate in Free Cash Flow
Return Relative to Current Share Price
DRRX, AGHC, ALC, AMRN, and FGEN can be thought of as valuation peers to DRAD, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.
LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.
SUWANEE, GA / ACCESSWIRE / August 25, 2020 / Digirad Corporation (NASDAQ:DRAD; DRADP) ("Digirad" or the "Company"), a diversified holding company with three divisions: Healthcare, Building & Construction, and Real Estate & Investments, today announced that its management team will be presenting at the LD 500 Virtual Conference, on Tuesday, September 1st.